OR PathTrac (Tracking Intra-operative Bacterial Transmission)
|ClinicalTrials.gov Identifier: NCT03605498|
Recruitment Status : Completed
First Posted : July 30, 2018
Last Update Posted : March 1, 2019
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||83 participants|
|Official Title:||An Investigation of Novel Technology to Bring Genomic Analysis to the Patient Bedside to Systematically Track and Report on ESKAPE Bacterial Transmission in Today's Operating Room Environments|
|Actual Study Start Date :||September 5, 2017|
|Actual Primary Completion Date :||February 12, 2018|
|Actual Study Completion Date :||February 12, 2018|
- Identify transmission dynamics of pathogenic bacteria (i.e. Staph aureus). [ Time Frame: Intraoperative period ]Focus on how Staph aureus is transmitted in the operating room by identifying key areas of origin.
- Intraoperative clonal transmission of Staph aureus. [ Time Frame: Intraoperative period ]Monitor locations throughout the operating room to document clonal transmission from the area of origin.
- Identify the modes of transmission of pathogenic bacteria ((i.e. Staph aureus). [ Time Frame: Intraoperative period ]If transmission of Staph aureus from the site of origin to another site in the operating room arena is documented, identify the modes of transmission.
- Monitor for post operative healthcare associated infections. [ Time Frame: Up to 30 days following surgery ]Monitor for the presence or absence of healthcare associated infection after undergoing an operative procedure.
- Surveil for molecular links between pathogenic organisms. [ Time Frame: Up to 30 days following surgery ]Seek to identify molecular links between causative organisms of infection and bacteria found in the operating room at the time of surgery.
Biospecimen Retention: Samples With DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03605498
|United States, Iowa|
|University of Iowa Hospitals and Clinics|
|Iowa City, Iowa, United States, 52242|
|Principal Investigator:||Sundara Reddy, MBBS, FRCA||University of Iowa|